Carlos Lopez serves as the Senior Vice President and General Counsel at NIAGEN BIOSCIENCE INC, a leading biotechnology firm focused on developing innovative therapies for complex diseases. With over two decades of experience in the legal and biotechnology sectors, Lopez has become a pivotal figure in guiding NIAGEN through its complex legal and regulatory landscape. Before joining NIAGEN, Lopez held significant roles at several top-tier biotech companies, including a stint as Vice President of Legal Affairs at GenTech Solutions, where he was instrumental in navigating the company through multiple high-stakes mergers and acquisitions. At NIAGEN, Lopez's role encompasses overseeing all legal aspects of the company's operations, from intellectual property management to compliance with international regulations. His strategic foresight and meticulous attention to detail have been crucial in securing patents for NIAGEN's groundbreaking therapies, thereby strengthening the company's market position. Lopez's leadership has also been vital in fostering a culture of ethical compliance and integrity within the organization. His achievements include successfully defending NIAGEN in a landmark patent infringement lawsuit, which not only protected the company's assets but also set a precedent in the industry. Lopez's contributions continue to be a driving force behind NIAGEN's mission to bring life-changing treatments to patients worldwide.